| African American, No. (%) | Non-Hispanic White, No. (%) | ||
---|---|---|---|---|
Age at diagnosis,** y | ||||
  25 - 59 | 129 | 28.1 | 563 | 18.8 |
  60 - 69 | 99 | 21.6 | 629 | 21.0 |
  70 - 79 | 138 | 30.1 | 980 | 32.7 |
  ≥ 80 | 93 | 20.3 | 829 | 27.6 |
Women** | 275 | 59.9 | 1,574 | 52.4 |
Neighborhood poverty prevalence,**% | Â | Â | Â | Â |
  < 5 | 31 | 6.8 | 1,240 | 41.3 |
  5 - 29 | 76 | 16.6 | 1,131 | 37.7 |
  ≥ 301 | 352 | 76.7 | 630 | 21.0 |
Primary health insurers** | Â | Â | Â | Â |
  Private | 194 | 42.3 | 1,409 | 47.0 |
  Medicare | 201 | 43.8 | 1,391 | 46.4 |
  Medicaid | 36 | 7.8 | 72 | 2.4 |
  Uninsured | 28 | 6.1 | 129 | 4.3 |
Stage at diagnosis | Â | Â | Â | Â |
  II | 184 | 40.1 | 1,270 | 42.3 |
  III | 132 | 28.8 | 927 | 30.9 |
  IV | 143 | 31.2 | 804 | 26.8 |
Tumor grade | Â | Â | Â | Â |
  I | 31 | 7.4 | 192 | 6.8 |
  II | 286 | 68.4 | 1,863 | 66.4 |
  III or IV2 | 101 | 24.2 | 752 | 26.8 |
  Missing data* | 41 | 8.9 | 194 | 6.5 |
Examined 12 or more RLN3 | 124 | 40.4 | 939 | 44.1 |
  Missing data | 9 | 2.8 | 67 | 3.0 |
Received chemotherapy* | 145 | 31.7 | 1,124 | 37.6 |
  Missing data | 2 | 0.4 | 9 | 0.3 |